leisure time -WSS

leisure time

author：focus 2025-09-03 07:53:54 - browse：95

Telehealth menopause treatment options displayed on cellphones emerging from a crack in the ground. -- health tech coverage from STAT — Molly Ferguson for STAT

At the turn of the century, nearly 18 million women in the United States were battling hot flashes, night sweats, and other symptoms of menopause with hormones. But in 2002, the therapy went into a free-fall when a landmark trial suggested treating menopause with estrogen and progesterone increased the risk of breast cancer and cardiovascular disease. The study was shut down early — and a year later, prescriptions had plummeted to nearly half what they had been in 2001.

More than two decades later, menopause experts have come to think about the results of the trial very differently. Newer research points to more benefits than risks for many healthy women under 60 treating menopause symptoms with hormone therapy. But many women who are good fits still aren’t getting treatment. “The pendulum has been slowly — too slowly — swinging back,” said OB-GYN Mike Green, chief medical officer of menopause telehealth company Winona.

Winona is part of a new generation of virtual-first health care companies aiming to give that pendulum a push. In the last five years, more than a dozen telehealth companies have started up to serve women in and approaching menopause, including with hormone therapy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： General Catalyst, Summa Health deal will turn on physician buy

WSS

PBM executives asked to testify by House panel

Novo Nordisk to expand supply of Wegovy for U.S. patients

Apple Vision Pro: A first look at health apps on the new VR headset

New Ultima Genomics DNA sequencer can read genome for $100

Brain technologies pose threats that are all too real, experts warn

Cognito secures funding to test medical device for Alzheimer's

focus

leisure time

knowledge

Novavax promises a turnaround & Lilly roils the obesity market

Class action alleges UnitedHealth concealed DOJ probe

Continuity nursing helped my family in our darkest PICU moments

Commercial surrogacy can be ethical, despite pope’s claims

New air purifier tech could be key to improving indoor air quality

Empower primary care with adequate payments and technology

Dobbs anniversary: the lost opportunity of abortion as health care

AI for drug discovery: Experts on separating hype from reality

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Empower primary care with adequate payments and technology

focus

Apple Vision Pro: A first look at health apps on the new VR headset

AltruBio raises $225 million to develop ulcerative colitis drug

Medicare drug price negotiation’s day in court

ARCH Venture Partners is raising $3 billion for a life sciences fund

Empower primary care with adequate payments and technology

Warren pushes Witty on UnitedHealth's control over physicians

focus

entertainment

leisure time

explore